Literature DB >> 16430720

Tissue levels of adiponectin, tumour necrosis factor-alpha, soluble intercellular adhesion molecule-1 and heart-type fatty acid-binding protein in human coronary atherosclerotic plaques.

Mehmet Karaduman1, Ali Sengul, Cagatay Oktenli, Aysel Pekel, Zeki Yesilova, Ugur Musabak, S Yavuz Sanisoglu, Celalettin Gunay, Oben Baysan, Ismail H Kocar, Harun Tatar, Metin Ozata.   

Abstract

BACKGROUND: There is little information available about any link between the levels of adiponectin, intercellular adhesion molecule-1 (ICAM-1), tumour necrosis factor-alpha (TNF-alpha) and heart-type fatty acid-binding protein (H-FABP) in coronary atherosclerotic plaque specimens. AIM: To analyse tissue levels of adiponectin, ICAM-1, TNF-alpha and H-FABP in the plaques obtained from coronary artery bypass grafting (CABG) and to evaluate whether there is any relationship between these variables and other characteristics. PATIENTS AND METHODS: Coronary artery specimens from 37 consecutive patients (28 men and nine women) at time of CABG procedure and preprocedural blood samples were obtained. Tissue concentrations of adiponectin, ICAM-1, TNF-alpha and H-FABP in the atherosclerotic plaques were measured.
RESULTS: Blood glucose and tissue levels of TNF-alpha and ICAM-1 were negatively correlated with tissue levels of adiponectin, whereas TNF-alpha was positively correlated with ICAM-1 in atherosclerotic plaques. In addition, there was a positive correlation between blood glucose and tissue levels of both TNF-alpha and ICAM-1. TNF-alpha and ICAM-1 levels in atherosclerotic plaques appear to progressively increase whereas adiponectin levels progressively decrease with smoking status. Atherosclerotic tissue levels of these substances are also altered in diabetes.
CONCLUSIONS: The data are in accord with those in prior publications on the detection and quantification of various inflammatory cytokines in atherosclerotic plaques. Our results indicate that diabetic state and smoking, in addition to other physiopathological mechanisms, may create a chronic inflammatory situation in the atherosclerotic process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16430720     DOI: 10.1111/j.1365-2265.2006.02448.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

1.  Variants in the adiponectin gene and serum adiponectin: the Coronary Artery Development in Young Adults (CARDIA) Study.

Authors:  Christina L Wassel; James S Pankow; David R Jacobs; Michael W Steffes; Na Li; Pamela J Schreiner
Journal:  Obesity (Silver Spring)       Date:  2010-04-15       Impact factor: 5.002

2.  Associations of SNPs in ADIPOQ and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis (MESA).

Authors:  Christina L Wassel; James S Pankow; Laura J Rasmussen-Torvik; Na Li; Kent D Taylor; Xiuqing Guo; Mark O Goodarzi; Walter R Palmas; Wendy S Post
Journal:  Obesity (Silver Spring)       Date:  2010-10-07       Impact factor: 5.002

3.  The associations between serum leptin, adiponectin and intercellular adhesion molecule-1 in hypercholesterolemic patients.

Authors:  Eunju Park; Min-Jeong Shin; Namsik Chung
Journal:  Nutr Res Pract       Date:  2007-03-31       Impact factor: 1.926

Review 4.  The Role of Endoplasmic Reticulum Stress in Cardiovascular Disease and Exercise.

Authors:  Junyoung Hong; Kwangchan Kim; Jong-Hee Kim; Yoonjung Park
Journal:  Int J Vasc Med       Date:  2017-08-10

5.  Effect of lower extremity bypass surgery on inflammatory reaction and endothelial dysfunction in type 2 diabetic patients.

Authors:  Pei-Hsuan Tsai; Jun-Jen Liu; Szu-Yuan Chou; Yao-Chung Chang; Sung-Ling Yeh
Journal:  Mediators Inflamm       Date:  2009-04-05       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.